1. Hotamisligil G, Arner P, Caro J, Atkinson R, Spiegelman B. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995. 95:2409–2415.
Article
2. Ogden C, Carroll M, Curtin L, McDowell M, Tabak C, Flegal K. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006. 295:1549–1555.
Article
3. Li W, Zheng H, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 2004. 92:1–21.
Article
4. DeFronzo R. Pathogenesis of NIDDM. A balanced overview. Diabetes care. 1992. 15:318–368.
Article
5. sjöholm A, Nyström T. Endothelial inflammation in insulin resistance. Lancet. 2005. 365:610–612.
Article
6. Ross JA, Auger MJ. Burke B, Lewis CE, editors. The biology of the macrophage. The macrophage. 2002. 2nd ed. Oxford: Oxford Medical Publications;1–72.
7. Kinne R, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester G. Macrophages in rheumatoid arthritis. Arthritis Research. 2000. 2:189–202.
8. Gai G, Jin S, Wang B, Li Y, Li C. The efficacy of Cordyceps militaris capsules in treatment of chronic bronchitis in comparison with Jinshuibao capsules. Chin J New Drugs. 2004. 13:169–171.
9. Paterson R. Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry. 2008. 69:1469–1495.
Article
10. Yoo H, Shin J, Cho J, Son C, Lee Y, Park S, Cho C. Effects of Cordyceps militaris extract on angiogenesis and tumor growth. Acta Pharmacologica Sinica. 2004. 25:657–665.
11. Kim H, Shrestha B, Lim S, Yoon D, Chang W, Shin D, Han S, Park S, Park J, Park H. Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol. 2006. 545:192–199.
Article
12. Yun Y, Han S, Lee S, Ko S, Lee C, Ha N, Kim K. Anti-diabetic effects of CCCA, CMESS, and cordycepin from Cordyceps militaris and the immune responses in streptozotocin-induced diabetic mice. Nat Pro Sci. 2003. 9:291–298.
13. Cho M, Lee D, Kim M, Sung J, Ham S. Antimutagenicity and cytotoxicity of cordycepin isolated from Cordyceps militaris. Food Sci Biotechnol. 2003. 12:472–475.
14. Majumder N, Dey R, Mathur R, Datta S, Maitra M, Ghosh S, Saha B, Majumdar S. An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages. Glycoconj J. 2006. 23:675–686.
Article
15. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends in immunology. 2004. 25:677–686.
Article
16. Furchgott R, Cherry P, Zawadzki J, Jothianandan D. Endothelial cells as mediators of vasodilation of arteries. J Cardiovasc Pharmacol. 1984. 6:S336–S343.
Article
17. Rausch-Fan X, Matejka M. From plaque formation to periodontal disease, is there a role for nitric oxide? Eur J Clin Invest. 2008. 31:833–835.
Article
18. Wei X, Charles I, Smith A, Ure J, Feng G, Huang F, Xu D, Muller W, Moncada S, Liew F. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 1995. 375:408–411.
Article
19. Haddad JJ, Safieh-Garabedian B, Saadé NE, Kanaan SA, Land SC. Chemioxyexcitation (delta pO2/ROS)-dependent release of IL-1 beta, IL-6 and TNF-alpha: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium. Cytokine. 2001. 13:138–147.
Article
20. Moestrup S, Moller H. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Annals of Medicine. 2004. 36:347–354.
Article
21. Hotamisligil G, Shargill N, Spiegelman B. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993. 259:87–91.
Article
22. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects. J Bio Chem. 2003. 278:45777–45784.
Article
23. Uysal KT, Wiesbrock SM, Hotamisligil GS. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology. 1998. 139:4832–4838.
Article
24. Xu H, Barnes G, Yang Q, Tan G, Yang D, Chou C, Sole J, Nichols A, Ross J, Tartaglia L. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003. 112:1821–1830.
Article
25. Bujalska I, Kumar S, Stewart P. Does central obesity reflect Cushing's disease of the omentum? Lancet. 1997. 349:1210–1213.
Article
26. Tomlison J, Stewart P. 11β-Hydroxysteroid dehydrogenase type I as a therapeutic target in the metabolic syndrome. Drug Discov Today. 2005. 2:93–96.
27. Wu H, Ghosh S, Perrard X, Feng L, Garcia G, Perrard J, Sweeney J, Peterson L, Chan L, Smith C. T-cell accumulation and regulated on activation, normal T cell expressed secreted upregulation in adipose tissue in obesity. Circulation. 2007. 115:1029.
Article
28. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990. 347:645–650.
Article
29. Marx N, Sukhova G, Murphy C, Libby P, Plutzky J. Macrophages in human atheroma contain pparγ differentiation-dependent peroxisomal proliferator-activated receptorγ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. ASIP. 1998. 153:17–23.
30. Nicklin M, Hughes D, Barton J, Ure J, Duff G. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med. 2000. 191:303–312.
Article
31. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med. 2000. 191:313–320.
Article
32. Yamshchikov V, Mishina M, Cominelli F. A possible role of IL-1ra 3'-untranslated region in modulation of protein production. Cytokine. 2002. 17:98–107.
Article
33. Beach L, Ross J. Cordycepin. An inhibitor of newly synthesized globin messenger RNA. J Bio Chem. 1978. 253:2628–2632.
Article
34. Dazzi F, D'andrea E, Biasi G, De Silvestro G, Gaidano G, Schena M, Tison T, Vianello F, Girolami A, Caligaris-Cappio F. Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. Clin Immunol Immunopathol. 1995. 75:26–32.
Article
35. Deeths MJ, Mescher MF. ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1. Eur J Immunol. 1999. 29:45–53.
Article